Skip to main content
Adam Comer, MD, Neurology, Indianapolis, IN

AdamDanielComerMD

Neurology Indianapolis, IN

Neurophysiology

Neuromuscular Medicine, Neurophysiology

Dr. Comer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Comer's full profile

Already have an account?

  • Office

    355 W 16th St
    Ste 3200
    Indianapolis, IN 46202
    Phone+1 317-948-5450
    Fax+1 317-962-2141

Summary

  • Dr. Adam Comer is a neurologist in Indianapolis, IN and is affiliated with multiple hospitals in the area, including Indiana University Health Methodist Hospital, Eskenazi Health, and Roudebush VA Medical Center. He received his medical degree from Indiana University School of Medicine and has been in practice 5 years. He specializes in neurophysiology and is experienced in electromyography, neuromuscular medicine, neuromuscular ultrasound, and muscular dystrophy.

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Clinical Neurophysiology, 2016 - 2017
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Neurology, 2013 - 2016
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 2012

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2023 - 2026
  • IN State Medical License
    IN State Medical License 2016 - 2025
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Psychiatry and Neurology Clinical Neurophysiology

Publications & Presentations

PubMed

Press Mentions

  • Neurologists at IU Administer First-of-Its-Kind FDA-Approved Gene Therapy
    Neurologists at IU Administer First-of-Its-Kind FDA-Approved Gene TherapyJanuary 25th, 2024

Professional Memberships